Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Brain-computer Interface System Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
Global Brain-computer Interface System Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
Industry: Medical Devices & Consumables
Published Date: 2026-07-26
Pages: 195 Pages
Report ld: 6982465
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
KEY FINDINGS
2025 global deliveries reached approximately 440,000 Brain-computer Interface Systems
Average manufacturer selling price was approximately US$1,900 per delivered system
Non-invasive systems represented the majority of global unit shipments
Medical and research applications concentrated most professional system value
Brain-computer Interface System Market Size(US$)
CAGR 2026-2032
20.4%
Market Size,2032
USD 2,962
Million
Market Snapshot
Market Size in 2026 (Value)
US$ 972 million
Market Forecast in 2032(Value)
US$ 2,962 million
CAGR
20.4%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Brain-computer Interface System market size was US$ 836 million in 2025 and is forecast to reach a readjusted size of US$ 2962 million by 2032 with a CAGR of 20.4% during the forecast period 2026-2032.
Brain-computer Interface System refers to an integrated hardware-software system that establishes a direct information pathway between neural activity and computers, assistive devices, rehabilitation equipment, robots, transportation systems or neuromodulation devices. Also referred to as a BCI system or brain-machine interface system, the product normally combines neural-signal electrodes or implantable interfaces, low-noise analog front ends, amplification and digital conversion modules, wired or wireless transmission, real-time preprocessing and neural-decoding software, application management software, and an external control, feedback or stimulation device. The research scope covers non-invasive systems based mainly on EEG, fNIRS or MEG; semi-invasive systems using epidural, cortical-surface or endovascular interfaces; and invasive systems using intracortical penetrating electrodes to capture spikes and local field potentials. Products range from low-channel portable headsets to high-density platforms exceeding 128 channels. Their core functions include neural-state recognition, movement-intention decoding, communication restoration, external-device control, neurofeedback, functional compensation, rehabilitation training and closed-loop neurological treatment. The market focuses on deliverable system-level products with proprietary acquisition hardware, integrated decoding functions and an identifiable interaction or feedback workflow across medical, research, consumer, industrial, transportation and specialized applications.
MARKET TRENDS
The Brain-computer Interface System market is shifting from competition in standalone EEG amplifiers or wearable headsets toward competition in complete neural-interaction architectures. Customers increasingly assess signal-to-noise ratio, synchronization accuracy, motion-artifact suppression, preparation time, decoding latency, cross-session stability, software openness and compatibility with external equipment rather than relying on channel count alone. Non-invasive products are moving toward dry or semi-dry electrodes, wireless acquisition, compact form factors, real-time APIs and multimodal synchronization with eye tracking, EMG, motion capture, stimulation, virtual reality and robotics. Semi-invasive systems are developing along epidural, cortical-surface and endovascular routes that seek a balance between information quality, surgical complexity and long-term stability. Intracortical platforms continue to pursue higher-density neuronal recording for precise cursor, speech and robotic control, but face more demanding implantation, packaging and calibration requirements. The long-term product direction is an adaptive closed loop in which signal acquisition, decoding, device control and sensory or therapeutic feedback are continuously optimized as one system. Commercial differentiation is consequently migrating toward proprietary neural datasets, application-specific workflows, automated calibration, home-use capability and longitudinal performance rather than basic access to raw brain signals.
MARKET SEGMENTATION
By Company
- Neuralink
- OpenBCI
- NeuroPace
- Emotiv
- NeuroSky
- ANT Neuro
- Blackrock Neurotech
- Synchron
- g.tec medical engineering GmbH
- Brain Products
- Bitbrain
- Precision Neuroscience
- Paradromics
- InteraXon
- Neurable
- Mentalab
- mBrainTrain
- Neuroelectrics
- CGX Systems (formerly Cognionics)
- Neurosity
- Wearable Sensing
- Compumedics Neuroscan
- SmartCap(Wenco)
- Shimadzu
- BrainCo
- Neuracle Technology
- CUSOFT
- Deayea
- Entertech
- HNNK
- StairMed
- NeuroXess
- Enlight Medical
- Tiankai Suishi (Tianjin) Intelligent Technology Co., Ltd.
- Hanix
- Zhongdian Yunnao (Tianjin) Technology Co., Ltd.
- Beijing Xinzhida Neural Technology Co., Ltd
- Nanjing Vishee Medical Technology Co., Ltd.
- Xiangyu Medical Co.,Ltd.
- Jiangsu Apon Medical Technology Co.,Ltd.
- Boling Brain Machine (Hangzhou) Technology Co., Ltd.
- Medlander
- Shanghai HeartCare Medical Technology Corporation Limited
- Beijing Chieftain Control Engineering Technology Co., Ltd.
- Kingfar International,Inc.
- Suzhou Nianji Intelligent Technology Co., Ltd.
- Beijing Zhiran Medical Technology Co., Ltd
- Greatthink Medical Technology
- Danyang Huichuang Medical Equipment Co., Ltd.
- OYMotion
- Aura MedTech
- Casibrain
- Gestala
- WE-LINKING
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Non-Invasive
- Partially Invasive
- Invasive
Segment by Application
- Medical Rehabilitation
- Daily Life and Entertainment Consumption
- Industrial Control
- Traffic Driving
- Research & Education
- Military and Others
Segment by Category
- 1 To 8 Channels
- 9 To 32 Channels
- 33 To 128 Channels
- 128 To 256 Channels
Segment by Division
- EEG
- ECoG
- Spikes & LFPs
- fNIRS, MEG and Others
MARKET DYNAMICS
Drivers
Growth is being driven by converging demand from neuroscience research, neurological rehabilitation, functional compensation, assistive communication and closed-loop treatment. Universities and research institutions require configurable systems for neuro-AI, cognitive neuroscience, multimodal experiments and human-machine interaction, while hospitals need products capable of producing measurable clinical or functional outcomes for patients with spinal-cord injury, stroke, epilepsy and severe communication impairment. Improvements in flexible electrodes, low-noise analog front ends, wireless transmission, embedded computing and machine-learning decoding are making systems more portable and usable outside controlled laboratories. Policy and payment infrastructure are also beginning to move in parallel with technology. China’s brain-computer interface industrial policy identifies electrodes, dedicated chips, complete systems, standards and medical, industrial and consumer applications as priority development areas. The National Healthcare Security Administration has established service-price categories for invasive implantation, device removal and non-invasive fitting, while the NMPA approved an implantable hand-function compensation system in March 2026. These developments reduce uncertainty around clinical workflow and create a more defined transition from research projects to regulated product deployment.
Restraints
The principal restraint is the performance gap between laboratory demonstration and reliable daily use. Non-invasive EEG systems are affected by skull attenuation, electrode-contact variation, muscle and eye artefacts, head movement and environmental noise, making decoding accuracy and repeatability highly dependent on the user, task and operating environment. Additional channels may improve spatial coverage but also increase preparation time, calibration complexity, data-processing requirements and operator dependence. Semi-invasive and invasive systems carry substantially higher development and delivery costs related to biocompatible materials, microfabrication, hermetic packaging, sterile production, neurosurgery, clinical trials and long-term follow-up. Endovascular approaches must manage vascular access, anatomical limitations and antithrombotic requirements, while cortical-surface and intracortical systems face infection, tissue response, electrode migration and signal degradation risks. Medical adoption also depends on physician training, hospital capacity, reimbursement and evidence that benefits persist beyond selected clinical-study participants. These limitations create a highly uneven market in which low-cost systems can scale rapidly by volume, while high-value medical systems require long commercialization cycles and significant post-market support.
Opportunities
The most immediate opportunities lie in converting general-purpose neural acquisition platforms into validated systems for defined workflows. Home and community rehabilitation can combine portable EEG hardware, intention decoding, robotic gloves, functional electrical stimulation or exoskeletons with clinician-facing software and remote model updates. Assistive communication products can extend from cursor control to text generation, environmental control and robotic-device operation for patients with paralysis or amyotrophic lateral sclerosis. Closed-loop neurological treatment offers a separate high-value opportunity in which continuous neural monitoring triggers personalized stimulation, with epilepsy providing the most established commercial model. Consumer and enterprise products may integrate brain sensing into headphones, headbands, VR equipment, safety wearables and driver-monitoring systems, provided that measurable benefits justify continued use. Semi-invasive systems may open a clinically relevant middle path between non-invasive accessibility and intracortical information density. China’s approval of an epidural hand-function compensation system, Precision Neuroscience’s FDA-cleared cortical interface, and advancing endovascular and intracortical clinical programs indicate that multiple interface routes can coexist rather than converge on a single dominant architecture.
Challenges
Long-term market development requires technical reliability, clinical evidence, regulatory compliance and sustainable economics to be achieved simultaneously. Neural signals differ materially across users and drift over time, creating persistent challenges in model transfer, recalibration and performance validation. Implantable systems must maintain signal quality while minimizing heat, power consumption, tissue reaction, wireless-transmission failure and replacement risk. The sector also lacks fully harmonized terminology, performance benchmarks, channel-count definitions, data formats and interoperability standards, complicating product comparison and multi-centre validation. Brain data introduces additional requirements around informed consent, cybersecurity, data ownership, mental privacy and the permitted use of neural information. Commercial risk is equally important. Consumer products may show measurable neural-state signals without delivering sufficient recurring utility, while medical companies can generate high product gross margins but still incur substantial clinical, regulatory, physician-training and sales expenses. Scaling therefore depends not only on decoding accuracy but also on standard surgical procedures, application-specific evidence, reimbursement, service capacity and the ability to support patients over extended periods.
INDUSTRY CHAIN ANALYSIS
The upstream Brain-computer Interface System chain consists of wet, dry and semi-dry scalp electrodes; flexible epidural and cortical electrode arrays; penetrating microelectrodes; endovascular electrode structures; conductive and biocompatible materials; hermetic packaging; low-noise amplifiers; analog front-end chips; ADCs; processors; wireless-communication and power modules; batteries; connectors; surgical tools; stimulation modules; and precision mechanical components. Upstream specifications determine signal amplitude, bandwidth, spatial resolution, channel density, noise, power consumption, thermal safety, comfort, implantation difficulty and long-term stability. Non-invasive products place greater emphasis on electrode consistency, ergonomic wearability, rapid setup and resistance to motion artefacts. Implantable products allocate more value and development expenditure to microfabrication, flexible materials, packaging reliability, sterilization, wireless power and surgical compatibility.
Midstream manufacturers integrate the neural interface, acquisition electronics, signal transmission, real-time decoding, application software and external feedback device into a deliverable system. Value creation is concentrated in reproducible signal acquisition, low-latency processing, automated calibration, cross-session model stability, integration with third-party devices and regulatory or clinical validation. Standardized low-channel hardware faces increasing price competition, shifting profit toward software licenses, development tools, validated application modules, consumables and technical services. Research-grade and medical systems retain stronger pricing power because customers require data quality, synchronization, technical support and workflow continuity. Implantable and closed-loop systems can achieve high product margins, but those margins must fund clinical trials, quality systems, regulatory submissions, surgical training and long-term patient management. Downstream customers include universities, hospitals, rehabilitation centres, neurological clinics, assistive-technology providers, consumer-electronics companies, industrial operators, transportation users and specialized government institutions.
SEGMENT INSIGHTS
By interface type, non-invasive systems account for the majority of shipments because they offer lower risk, broader availability and shorter procurement cycles across education, research, consumer interaction and rehabilitation. Semi-invasive systems cover epidural, cortical-surface and endovascular routes that record population-level cortical activity without penetrating neural tissue. These architectures generally offer stronger and more spatially specific signals than scalp EEG while reducing some of the tissue-response risks associated with intracortical arrays. Intracortical systems record spikes and local field potentials and provide the highest potential information density for precise movement, speech and sensory decoding, but their deployment remains constrained by surgical risk, long-term signal stability and high development costs. EEG remains the dominant signal modality by unit volume, while ECoG, spikes and LFPs concentrate high-value clinical and advanced research activity. fNIRS, MEG and multimodal configurations occupy specialized research, cognitive assessment and hybrid-interface niches.
Low-channel 1–8 and 9–32-channel products dominate portable, educational, consumer and rapid-development applications. Systems in the 33–128-channel range serve advanced neuroscience, high-density EEG, brain mapping and complex multimodal experiments, while platforms above 128 channels, including 128–256-channel and higher-density configurations, support detailed cortical recording and advanced implantable research. Price and margin differences between these segments are substantial. Neuracle Technology’s prospectus reported 488 EEG acquisition systems sold in 2025 at an average tax-exclusive price of RMB159,100 per system and a 77.92% gross margin, demonstrating the economics of specialized professional equipment relative to the global weighted average price. Within applications, research and education provide the broadest established customer base, while medical rehabilitation, functional compensation and neurological treatment concentrate higher system value. Daily-life consumption, industrial control and transportation remain earlier-stage markets in which adoption depends on comfort, calibration speed and demonstrable operational benefits.
DOWNSTREAM MARKET OPPORTUNITIES
Downstream demand is becoming more application-specific. Research users require raw-data access, precise event synchronization, configurable channels and compatibility with MATLAB, Python, BCI2000, OpenViBE and multimodal laboratory equipment. Medical customers require repeatable protocols, clinical-grade reliability, therapist or physician interfaces and connectivity with robotic gloves, functional electrical stimulation, wheelchairs, prostheses and neuromodulation equipment. In rehabilitation, the commercial opportunity increasingly combines immediate functional compensation with repeated training intended to promote longer-term recovery. Closed-loop treatment customers place greater emphasis on biomarker detection, stimulation accuracy, longitudinal data and patient-management services. Daily-life and entertainment products require unobtrusive form factors and minimal calibration; industrial and transportation applications require robust state monitoring under motion, vibration and electromagnetic interference. Military and specialized government applications are more likely to focus on training, cognitive-load assessment, fatigue monitoring and complex human-machine interaction. Across these markets, suppliers able to deliver a validated end-to-end workflow rather than a generic signal stream are positioned to capture a larger proportion of downstream value.
REGIONAL INSIGHTS
Fastest-Growing Region: Asia Pacific
North America remains the principal high-value clinical and venture-backed development region. It contains commercially established closed-loop neurological treatment, intracortical clinical programs, endovascular systems and cortical-surface interfaces. NeuroPace provides a commercial benchmark: its RNS System generated US$81.7 million in 2025 revenue with an 81.9% product gross margin. Neuralink is conducting trials for computer and robotic-arm control, Synchron is evaluating an investigational endovascular system, Precision Neuroscience has obtained FDA clearance for its cortical interface, and Paradromics received authorization to initiate a clinical study of its fully implantable system. The region’s advantages include specialist clinical centres, regulatory experience, medical-device financing and access to software and AI capabilities, although development and patient-support costs remain high.
- XX.X%CAGR*
- XXXXUS$ Million
- XXXXREGIONAL SHARE
BY TYPE,2021-2032(US $ MILLION)
Non-Invasive
Partially Invasive
Invasive
BY APPLICATION，2021-2032(US $ MILLION）
Medical Rehabilitation
Daily Life and Entertainment Consumption
Industrial Control
Traffic Driving
Research & Education
Military and Others
Europe has a strong position in research-grade EEG, neurorehabilitation, multimodal acquisition and open scientific software ecosystems, supported by companies such as g.tec, Brain Products, ANT Neuro, Bitbrain, Mentalab, mBrainTrain and Neuroelectrics. China is developing a broader manufacturing and application base spanning non-invasive research systems, rehabilitation equipment, consumer products and multiple implantable routes. The NMPA approval of an epidural Brain-computer Interface System, the establishment of medical-service price categories and expanding clinical programs have strengthened China’s position in early medical commercialization. Japan retains capabilities in fNIRS, MEG and clinical neurodiagnostic equipment, while South Korea, Taiwan and Southeast Asia remain more concentrated in research institutions, components, clinical collaboration and application development than in globally scaled system brands. Regional competition is therefore differentiated: North America leads high-value clinical innovation, Europe remains strong in research platforms, and China is accelerating full-chain localization and clinical deployment.
COMPETITIVE LANDSCAPE ANALYSIS
The Brain-computer Interface System market has a layered competitive structure. In commercial non-invasive research and development platforms, g.tec, Brain Products, ANT Neuro, OpenBCI, Emotiv, NeuroSky, Bitbrain, Neuroelectrics, Mentalab, mBrainTrain, CGX Systems, Wearable Sensing, Compumedics Neuroscan, Neuracle Technology and BrainCo compete through signal quality, channel density, wireless performance, electrode preparation, synchronization, software openness and global research-channel coverage. InteraXon, Neurable, Neurosity and SmartCap emphasize consumer, enterprise or industrial form factors and applied neural-state interaction. In medical rehabilitation, Chinese suppliers such as BrainCo, Neuracle Technology, CUSOFT, Deayea, Entertech, HNNK, Vishee Medical, Xiangyu Medical, Medlander, Longest and other specialist developers compete through hospital access, rehabilitation-device integration and localized clinical service. The implantable and closed-loop segment is technologically fragmented: Neuralink, Paradromics and Blackrock Neurotech pursue intracortical interfaces; Precision Neuroscience focuses on cortical-surface access; Synchron uses an endovascular route; NeuroPace operates an established responsive neurostimulation business; and Neuracle Technology has commercialized an epidural functional-compensation system in China. StairMed, NeuroXess, Enlight Medical, Xinzhida, Zhirun Medical and other Chinese developers are advancing different implantable architectures and clinical pipelines. Competitive advantage increasingly depends on control of the complete stack—electrodes, acquisition chips, wireless transmission, decoding software, clinical data, regulatory evidence, external devices and long-term service. Scale in low-cost hardware alone is unlikely to establish durable leadership, while companies possessing validated workflows and proprietary longitudinal neural data can sustain stronger pricing and higher entry barriers.
REPORT SCOPE
The global Brain-computer Interface System market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2021-2032.
CHAPTER OUTLINE
Chapter 1: Report scope, segment-level executive summary (by Type, by Application) and market evolution across the short, mid and long term
Chapter 2: Quantitative analysis of Brain-computer Interface System sales and revenue at global, regional, and country levels, highlighting market size and growth potential by region
Chapter 3: Competitive landscape of Brain-computer Interface System manufacturers (sales, revenue, pricing, market share, industry rankings, and M&A / expansion plans)
Chapter 4: by Type-based segmentation analysis (sales, revenue, pricing, and growth potential) to identify blue-ocean product segments
Chapter 5: by Application-based segmentation analysis (sales, revenue, pricing, and growth potential) to uncover high-value downstream markets
Chapter 6: Regional breakdown by company, customer, by Type and by Application (sales, revenue, and pricing for each segment)
Chapter 7: Key manufacturer profiles –company overview, Brain-computer Interface System product descriptions and specifications, revenue, gross margins, and recent developments
Chapter 8: Industry chain analysis – upstream raw materials, manufacturing links, and downstream application sectors
Chapter 9: Sales channels and distributor analysis – routes to market and key customer interfaces
Chapter 10: Market dynamics – trends, drivers, restraints, risks for manufacturers, and the impact of relevant industry policies
Chapter 11: Key findings, main takeaways, and overall conclusions of the report.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Brain-computer Interface System value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Brain-computer Interface System Product Scope
1.2 Brain-computer Interface System by Type
1.2.1 Global Brain-computer Interface System Sales by Type (2021, 2025 & 2032)
1.2.2 Non-Invasive
1.2.3 Partially Invasive
1.2.4 Invasive
1.3 Brain-computer Interface System by Application
1.3.1 Global Brain-computer Interface System Sales Comparison by Application (2021, 2025 & 2032)
1.3.2 Medical Rehabilitation
1.3.3 Daily Life and Entertainment Consumption
1.3.4 Industrial Control
1.3.5 Traffic Driving
1.3.6 Research & Education
1.3.7 Military and Others
1.4 Global Brain-computer Interface System Market Estimates and Forecasts (2021-2032)
1.4.1 Global Brain-computer Interface System Market Size (Value) and Growth Rate (2021-2032)
1.4.2 Global Brain-computer Interface System Market Size (Volume) and Growth Rate (2021-2032)
1.4.3 Global Brain-computer Interface System Price Trends (2021-2032)
1.5 Assumptions and Limitations
2 Market Size and Prospects by Region
2.1 Global Brain-computer Interface System Market Size by Region: 2021 VS 2025 VS 2032
2.2 Global Brain-computer Interface System Historical Market Scenario by Region (2021-2026)
2.2.1 Global Brain-computer Interface System Sales Market Share by Region (2021-2026)
2.2.2 Global Brain-computer Interface System Revenue Market Share by Region (2021-2026)
2.3 Global Brain-computer Interface System Market Estimates and Forecasts by Region (2027-2032)
2.3.1 Global Brain-computer Interface System Sales Estimates and Forecasts by Region (2027-2032)
2.3.2 Global Brain-computer Interface System Revenue Forecast by Region (2027-2032)
2.4 Major Regions and Emerging Market Analysis
2.4.1 North America Brain-computer Interface System Market Size and Prospects (2021-2032)
2.4.2 Europe Brain-computer Interface System Market Size and Prospects (2021-2032)
2.4.3 China Brain-computer Interface System Market Size and Prospects (2021-2032)
2.4.4 Japan Brain-computer Interface System Market Size and Prospects (2021-2032)
3 Global Market Size by Type
3.1 Global Brain-computer Interface System Historical Market Review by Type (2021-2026)
3.1.1 Global Brain-computer Interface System Sales by Type (2021-2026)
3.1.2 Global Brain-computer Interface System Revenue by Type (2021-2026)
3.1.3 Global Brain-computer Interface System Average Price by Type (2021-2026)
3.2 Global Brain-computer Interface System Market Estimates and Forecasts by Type (2027-2032)
3.2.1 Global Brain-computer Interface System Sales Forecast by Type (2027-2032)
3.2.2 Global Brain-computer Interface System Revenue Forecast by Type (2027-2032)
3.2.3 Global Brain-computer Interface System Price Forecast by Type (2027-2032)
3.3 Representative Players for Different Types of Brain-computer Interface System
4 Global Market Size by Application
4.1 Global Brain-computer Interface System Historical Market Review by Application (2021-2026)
4.1.1 Global Brain-computer Interface System Sales by Application (2021-2026)
4.1.2 Global Brain-computer Interface System Revenue by Application (2021-2026)
4.1.3 Global Brain-computer Interface System Average Price by Application (2021-2026)
4.2 Global Brain-computer Interface System Market Estimates and Forecasts by Application (2027-2032)
4.2.1 Global Brain-computer Interface System Sales Forecast by Application (2027-2032)
4.2.2 Global Brain-computer Interface System Revenue Forecast by Application (2027-2032)
4.2.3 Global Brain-computer Interface System Price Forecast by Application (2027-2032)
4.3 New Sources of Growth in Brain-computer Interface System Applications
5 Competition Landscape by Players
5.1 Global Brain-computer Interface System Sales by Player (2021-2026)
5.2 Global Top Brain-computer Interface System Players by Revenue (2021-2026)
5.3 Global Brain-computer Interface System Market Share by Company Type (Tier 1, Tier 2, and Tier 3), based on Brain-computer Interface System revenue as of 2025
5.4 Global Brain-computer Interface System Average Price by Company (2021-2026)
5.5 Global Key Manufacturers of Brain-computer Interface System, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Brain-computer Interface System, Product Type & Application
5.7 Global Key Manufacturers of Brain-computer Interface System, Date of Entry into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Regional Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Brain-computer Interface System Sales by Company
6.1.1.1 North America Brain-computer Interface System Sales by Company (2021-2026)
6.1.1.2 North America Brain-computer Interface System Revenue by Company (2021-2026)
6.1.2 North America Brain-computer Interface System Sales Breakdown by Type (2021-2026)
6.1.3 North America Brain-computer Interface System Sales Breakdown by Application (2021-2026)
6.1.4 North America Brain-computer Interface System Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Brain-computer Interface System Sales by Company
6.2.1.1 Europe Brain-computer Interface System Sales by Company (2021-2026)
6.2.1.2 Europe Brain-computer Interface System Revenue by Company (2021-2026)
6.2.2 Europe Brain-computer Interface System Sales Breakdown by Type (2021-2026)
6.2.3 Europe Brain-computer Interface System Sales Breakdown by Application (2021-2026)
6.2.4 Europe Brain-computer Interface System Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Brain-computer Interface System Sales by Company
6.3.1.1 China Brain-computer Interface System Sales by Company (2021-2026)
6.3.1.2 China Brain-computer Interface System Revenue by Company (2021-2026)
6.3.2 China Brain-computer Interface System Sales Breakdown by Type (2021-2026)
6.3.3 China Brain-computer Interface System Sales Breakdown by Application (2021-2026)
6.3.4 China Brain-computer Interface System Major Customers
6.3.5 China Market Trends and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Brain-computer Interface System Sales by Company
6.4.1.1 Japan Brain-computer Interface System Sales by Company (2021-2026)
6.4.1.2 Japan Brain-computer Interface System Revenue by Company (2021-2026)
6.4.2 Japan Brain-computer Interface System Sales Breakdown by Type (2021-2026)
6.4.3 Japan Brain-computer Interface System Sales Breakdown by Application (2021-2026)
6.4.4 Japan Brain-computer Interface System Major Customers
6.4.5 Japan Market Trends and Opportunities
7 Company Profiles and Key Figures
7.1 Neuralink
7.1.1 Neuralink Company Information
7.1.2 Neuralink Business Overview
7.1.3 Neuralink Brain-computer Interface System Sales, Revenue and Gross Margin (2021-2026)
7.1.4 Neuralink Brain-computer Interface System Products Offered
7.1.5 Neuralink Recent Development
7.2 OpenBCI
7.2.1 OpenBCI Company Information
7.2.2 OpenBCI Business Overview
7.2.3 OpenBCI Brain-computer Interface System Sales, Revenue and Gross Margin (2021-2026)
7.2.4 OpenBCI Brain-computer Interface System Products Offered
7.2.5 OpenBCI Recent Development
7.3 NeuroPace
7.3.1 NeuroPace Company Information
7.3.2 NeuroPace Business Overview
7.3.3 NeuroPace Brain-computer Interface System Sales, Revenue and Gross Margin (2021-2026)
7.3.4 NeuroPace Brain-computer Interface System Products Offered
7.3.5 NeuroPace Recent Development
7.4 Emotiv
7.4.1 Emotiv Company Information
7.4.2 Emotiv Business Overview
7.4.3 Emotiv Brain-computer Interface System Sales, Revenue and Gross Margin (2021-2026)
7.4.4 Emotiv Brain-computer Interface System Products Offered
7.4.5 Emotiv Recent Development
7.5 NeuroSky
7.5.1 NeuroSky Company Information
7.5.2 NeuroSky Business Overview
7.5.3 NeuroSky Brain-computer Interface System Sales, Revenue and Gross Margin (2021-2026)
7.5.4 NeuroSky Brain-computer Interface System Products Offered
7.5.5 NeuroSky Recent Development
7.6 ANT Neuro
7.6.1 ANT Neuro Company Information
7.6.2 ANT Neuro Business Overview
7.6.3 ANT Neuro Brain-computer Interface System Sales, Revenue and Gross Margin (2021-2026)
7.6.4 ANT Neuro Brain-computer Interface System Products Offered
7.6.5 ANT Neuro Recent Development
7.7 Blackrock Neurotech
7.7.1 Blackrock Neurotech Company Information
7.7.2 Blackrock Neurotech Business Overview
7.7.3 Blackrock Neurotech Brain-computer Interface System Sales, Revenue and Gross Margin (2021-2026)
7.7.4 Blackrock Neurotech Brain-computer Interface System Products Offered
7.7.5 Blackrock Neurotech Recent Development
7.8 Synchron
7.8.1 Synchron Company Information
7.8.2 Synchron Business Overview
7.8.3 Synchron Brain-computer Interface System Sales, Revenue and Gross Margin (2021-2026)
7.8.4 Synchron Brain-computer Interface System Products Offered
7.8.5 Synchron Recent Development
7.9 g.tec medical engineering GmbH
7.9.1 g.tec medical engineering GmbH Company Information
7.9.2 g.tec medical engineering GmbH Business Overview
7.9.3 g.tec medical engineering GmbH Brain-computer Interface System Sales, Revenue and Gross Margin (2021-2026)
7.9.4 g.tec medical engineering GmbH Brain-computer Interface System Products Offered
7.9.5 g.tec medical engineering GmbH Recent Development
7.10 Brain Products
7.10.1 Brain Products Company Information
7.10.2 Brain Products Business Overview
7.10.3 Brain Products Brain-computer Interface System Sales, Revenue and Gross Margin (2021-2026)
7.10.4 Brain Products Brain-computer Interface System Products Offered
7.10.5 Brain Products Recent Development
7.11 Bitbrain
7.11.1 Bitbrain Company Information
7.11.2 Bitbrain Business Overview
7.11.3 Bitbrain Brain-computer Interface System Sales, Revenue and Gross Margin (2021-2026)
7.11.4 Bitbrain Brain-computer Interface System Products Offered
7.11.5 Bitbrain Recent Development
7.12 Precision Neuroscience
7.12.1 Precision Neuroscience Company Information
7.12.2 Precision Neuroscience Business Overview
7.12.3 Precision Neuroscience Brain-computer Interface System Sales, Revenue and Gross Margin (2021-2026)
7.12.4 Precision Neuroscience Brain-computer Interface System Products Offered
7.12.5 Precision Neuroscience Recent Development
7.13 Paradromics
7.13.1 Paradromics Company Information
7.13.2 Paradromics Business Overview
7.13.3 Paradromics Brain-computer Interface System Sales, Revenue and Gross Margin (2021-2026)
7.13.4 Paradromics Brain-computer Interface System Products Offered
7.13.5 Paradromics Recent Development
7.14 InteraXon
7.14.1 InteraXon Company Information
7.14.2 InteraXon Business Overview
7.14.3 InteraXon Brain-computer Interface System Sales, Revenue and Gross Margin (2021-2026)
7.14.4 InteraXon Brain-computer Interface System Products Offered
7.14.5 InteraXon Recent Development
7.15 Neurable
7.15.1 Neurable Company Information
7.15.2 Neurable Business Overview
7.15.3 Neurable Brain-computer Interface System Sales, Revenue and Gross Margin (2021-2026)
7.15.4 Neurable Brain-computer Interface System Products Offered
7.15.5 Neurable Recent Development
7.16 Mentalab
7.16.1 Mentalab Company Information
7.16.2 Mentalab Business Overview
7.16.3 Mentalab Brain-computer Interface System Sales, Revenue and Gross Margin (2021-2026)
7.16.4 Mentalab Brain-computer Interface System Products Offered
7.16.5 Mentalab Recent Development
7.17 mBrainTrain
7.17.1 mBrainTrain Company Information
7.17.2 mBrainTrain Business Overview
7.17.3 mBrainTrain Brain-computer Interface System Sales, Revenue and Gross Margin (2021-2026)
7.17.4 mBrainTrain Brain-computer Interface System Products Offered
7.17.5 mBrainTrain Recent Development
7.18 Neuroelectrics
7.18.1 Neuroelectrics Company Information
7.18.2 Neuroelectrics Business Overview
7.18.3 Neuroelectrics Brain-computer Interface System Sales, Revenue and Gross Margin (2021-2026)
7.18.4 Neuroelectrics Brain-computer Interface System Products Offered
7.18.5 Neuroelectrics Recent Development
7.19 CGX Systems (formerly Cognionics)
7.19.1 CGX Systems (formerly Cognionics) Company Information
7.19.2 CGX Systems (formerly Cognionics) Business Overview
7.19.3 CGX Systems (formerly Cognionics) Brain-computer Interface System Sales, Revenue and Gross Margin (2021-2026)
7.19.4 CGX Systems (formerly Cognionics) Brain-computer Interface System Products Offered
7.19.5 CGX Systems (formerly Cognionics) Recent Development
7.20 Neurosity
7.20.1 Neurosity Company Information
7.20.2 Neurosity Business Overview
7.20.3 Neurosity Brain-computer Interface System Sales, Revenue and Gross Margin (2021-2026)
7.20.4 Neurosity Brain-computer Interface System Products Offered
7.20.5 Neurosity Recent Development
7.21 Wearable Sensing
7.21.1 Wearable Sensing Company Information
7.21.2 Wearable Sensing Business Overview
7.21.3 Wearable Sensing Brain-computer Interface System Sales, Revenue and Gross Margin (2021-2026)
7.21.4 Wearable Sensing Brain-computer Interface System Products Offered
7.21.5 Wearable Sensing Recent Development
7.22 Compumedics Neuroscan
7.22.1 Compumedics Neuroscan Company Information
7.22.2 Compumedics Neuroscan Business Overview
7.22.3 Compumedics Neuroscan Brain-computer Interface System Sales, Revenue and Gross Margin (2021-2026)
7.22.4 Compumedics Neuroscan Brain-computer Interface System Products Offered
7.22.5 Compumedics Neuroscan Recent Development
7.23 SmartCap(Wenco)
7.23.1 SmartCap(Wenco) Company Information
7.23.2 SmartCap(Wenco) Business Overview
7.23.3 SmartCap(Wenco) Brain-computer Interface System Sales, Revenue and Gross Margin (2021-2026)
7.23.4 SmartCap(Wenco) Brain-computer Interface System Products Offered
7.23.5 SmartCap(Wenco) Recent Development
7.24 Shimadzu
7.24.1 Shimadzu Company Information
7.24.2 Shimadzu Business Overview
7.24.3 Shimadzu Brain-computer Interface System Sales, Revenue and Gross Margin (2021-2026)
7.24.4 Shimadzu Brain-computer Interface System Products Offered
7.24.5 Shimadzu Recent Development
7.25 BrainCo
7.25.1 BrainCo Company Information
7.25.2 BrainCo Business Overview
7.25.3 BrainCo Brain-computer Interface System Sales, Revenue and Gross Margin (2021-2026)
7.25.4 BrainCo Brain-computer Interface System Products Offered
7.25.5 BrainCo Recent Development
7.26 Neuracle Technology
7.26.1 Neuracle Technology Company Information
7.26.2 Neuracle Technology Business Overview
7.26.3 Neuracle Technology Brain-computer Interface System Sales, Revenue and Gross Margin (2021-2026)
7.26.4 Neuracle Technology Brain-computer Interface System Products Offered
7.26.5 Neuracle Technology Recent Development
7.27 CUSOFT
7.27.1 CUSOFT Company Information
7.27.2 CUSOFT Business Overview
7.27.3 CUSOFT Brain-computer Interface System Sales, Revenue and Gross Margin (2021-2026)
7.27.4 CUSOFT Brain-computer Interface System Products Offered
7.27.5 CUSOFT Recent Development
7.28 Deayea
7.28.1 Deayea Company Information
7.28.2 Deayea Business Overview
7.28.3 Deayea Brain-computer Interface System Sales, Revenue and Gross Margin (2021-2026)
7.28.4 Deayea Brain-computer Interface System Products Offered
7.28.5 Deayea Recent Development
7.29 Entertech
7.29.1 Entertech Company Information
7.29.2 Entertech Business Overview
7.29.3 Entertech Brain-computer Interface System Sales, Revenue and Gross Margin (2021-2026)
7.29.4 Entertech Brain-computer Interface System Products Offered
7.29.5 Entertech Recent Development
7.30 HNNK
7.30.1 HNNK Company Information
7.30.2 HNNK Business Overview
7.30.3 HNNK Brain-computer Interface System Sales, Revenue and Gross Margin (2021-2026)
7.30.4 HNNK Brain-computer Interface System Products Offered
7.30.5 HNNK Recent Development
7.31 StairMed
7.31.1 StairMed Company Information
7.31.2 StairMed Business Overview
7.31.3 StairMed Brain-computer Interface System Sales, Revenue and Gross Margin (2021-2026)
7.31.4 StairMed Brain-computer Interface System Products Offered
7.31.5 StairMed Recent Development
7.32 NeuroXess
7.32.1 NeuroXess Company Information
7.32.2 NeuroXess Business Overview
7.32.3 NeuroXess Brain-computer Interface System Sales, Revenue and Gross Margin (2021-2026)
7.32.4 NeuroXess Brain-computer Interface System Products Offered
7.32.5 NeuroXess Recent Development
7.33 Enlight Medical
7.33.1 Enlight Medical Company Information
7.33.2 Enlight Medical Business Overview
7.33.3 Enlight Medical Brain-computer Interface System Sales, Revenue and Gross Margin (2021-2026)
7.33.4 Enlight Medical Brain-computer Interface System Products Offered
7.33.5 Enlight Medical Recent Development
7.34 Tiankai Suishi (Tianjin) Intelligent Technology Co., Ltd.
7.34.1 Tiankai Suishi (Tianjin) Intelligent Technology Co., Ltd. Company Information
7.34.2 Tiankai Suishi (Tianjin) Intelligent Technology Co., Ltd. Business Overview
7.34.3 Tiankai Suishi (Tianjin) Intelligent Technology Co., Ltd. Brain-computer Interface System Sales, Revenue and Gross Margin (2021-2026)
7.34.4 Tiankai Suishi (Tianjin) Intelligent Technology Co., Ltd. Brain-computer Interface System Products Offered
7.34.5 Tiankai Suishi (Tianjin) Intelligent Technology Co., Ltd. Recent Development
7.35 Hanix
7.35.1 Hanix Company Information
7.35.2 Hanix Business Overview
7.35.3 Hanix Brain-computer Interface System Sales, Revenue and Gross Margin (2021-2026)
7.35.4 Hanix Brain-computer Interface System Products Offered
7.35.5 Hanix Recent Development
7.36 Zhongdian Yunnao (Tianjin) Technology Co., Ltd.
7.36.1 Zhongdian Yunnao (Tianjin) Technology Co., Ltd. Company Information
7.36.2 Zhongdian Yunnao (Tianjin) Technology Co., Ltd. Business Overview
7.36.3 Zhongdian Yunnao (Tianjin) Technology Co., Ltd. Brain-computer Interface System Sales, Revenue and Gross Margin (2021-2026)
7.36.4 Zhongdian Yunnao (Tianjin) Technology Co., Ltd. Brain-computer Interface System Products Offered
7.36.5 Zhongdian Yunnao (Tianjin) Technology Co., Ltd. Recent Development
7.37 Beijing Xinzhida Neural Technology Co., Ltd
7.37.1 Beijing Xinzhida Neural Technology Co., Ltd Company Information
7.37.2 Beijing Xinzhida Neural Technology Co., Ltd Business Overview
7.37.3 Beijing Xinzhida Neural Technology Co., Ltd Brain-computer Interface System Sales, Revenue and Gross Margin (2021-2026)
7.37.4 Beijing Xinzhida Neural Technology Co., Ltd Brain-computer Interface System Products Offered
7.37.5 Beijing Xinzhida Neural Technology Co., Ltd Recent Development
7.38 Nanjing Vishee Medical Technology Co., Ltd.
7.38.1 Nanjing Vishee Medical Technology Co., Ltd. Company Information
7.38.2 Nanjing Vishee Medical Technology Co., Ltd. Business Overview
7.38.3 Nanjing Vishee Medical Technology Co., Ltd. Brain-computer Interface System Sales, Revenue and Gross Margin (2021-2026)
7.38.4 Nanjing Vishee Medical Technology Co., Ltd. Brain-computer Interface System Products Offered
7.38.5 Nanjing Vishee Medical Technology Co., Ltd. Recent Development
7.39 Xiangyu Medical Co.,Ltd.
7.39.1 Xiangyu Medical Co.,Ltd. Company Information
7.39.2 Xiangyu Medical Co.,Ltd. Business Overview
7.39.3 Xiangyu Medical Co.,Ltd. Brain-computer Interface System Sales, Revenue and Gross Margin (2021-2026)
7.39.4 Xiangyu Medical Co.,Ltd. Brain-computer Interface System Products Offered
7.39.5 Xiangyu Medical Co.,Ltd. Recent Development
7.40 Jiangsu Apon Medical Technology Co.,Ltd.
7.40.1 Jiangsu Apon Medical Technology Co.,Ltd. Company Information
7.40.2 Jiangsu Apon Medical Technology Co.,Ltd. Business Overview
7.40.3 Jiangsu Apon Medical Technology Co.,Ltd. Brain-computer Interface System Sales, Revenue and Gross Margin (2021-2026)
7.40.4 Jiangsu Apon Medical Technology Co.,Ltd. Brain-computer Interface System Products Offered
7.40.5 Jiangsu Apon Medical Technology Co.,Ltd. Recent Development
8 Brain-computer Interface System Manufacturing Cost Analysis
8.1 Brain-computer Interface System Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Brain-computer Interface System
8.4 Brain-computer Interface System Industrial Chain Analysis
9 Marketing Channels, Distributors and Customers
9.1 Marketing Channels
9.2 Brain-computer Interface System Distributors List
9.3 Brain-computer Interface System Customers
10 Brain-computer Interface System Market Dynamics
10.1 Brain-computer Interface System Industry Trends
10.2 Brain-computer Interface System Market Drivers
10.3 Brain-computer Interface System Market Challenges
10.4 Brain-computer Interface System Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Brain-computer Interface System Sales (US$ Million) Growth Rate by Type (2021, 2025 & 2032)
Table 2. Global Brain-computer Interface System Sales (US$ Million) Comparison by Application (2021, 2025 & 2032)
Table 3. Global Market Brain-computer Interface System Market Size (US$ Million) by Region:2021 VS 2025 VS 2032
Table 4. Global Brain-computer Interface System Sales (K Units) by Region (2021-2026)
Table 5. Global Brain-computer Interface System Sales Market Share by Region (2021-2026)
Table 6. Global Brain-computer Interface System Revenue (US$ Million) Market Share by Region (2021-2026)
Table 7. Global Brain-computer Interface System Revenue Share by Region (2021-2026)
Table 8. Global Brain-computer Interface System Sales (K Units) Forecast by Region (2027-2032)
Table 9. Global Brain-computer Interface System Sales Market Share Forecast by Region (2027-2032)
Table 10. Global Brain-computer Interface System Revenue (US$ Million) Forecast by Region (2027-2032)
Table 11. Global Brain-computer Interface System Revenue Share Forecast by Region (2027-2032)
Table 12. Global Brain-computer Interface System Sales by Type (K Units) & (2021-2026)
Table 13. Global Brain-computer Interface System Sales Share by Type (2021-2026)
Table 14. Global Brain-computer Interface System Revenue by Type (US$ Million) & (2021-2026)
Table 15. Global Brain-computer Interface System Average Price by Type (K US$/Unit) & (2021-2026)
Table 16. Global Brain-computer Interface System Sales by Type (K Units) & (2027-2032)
Table 17. Global Brain-computer Interface System Revenue by Type (US$ Million) & (2027-2032)
Table 18. Global Brain-computer Interface System Average Price by Type (K US$/Unit) & (2027-2032)
Table 19. Representative Players of Each Type
Table 20. Global Brain-computer Interface System Sales by Application (K Units) & (2021-2026)
Table 21. Global Brain-computer Interface System Sales Share by Application (2021-2026)
Table 22. Global Brain-computer Interface System Revenue by Application (US$ Million) & (2021-2026)
Table 23. Global Brain-computer Interface System Average Price by Application (K US$/Unit) & (2021-2026)
Table 24. Global Brain-computer Interface System Sales by Application (K Units) & (2027-2032)
Table 25. Global Brain-computer Interface System Revenue Market Share by Application (US$ Million) & (2027-2032)
Table 26. Global Brain-computer Interface System Average Price by Application (K US$/Unit) & (2027-2032)
Table 27. New Sources of Growth in Brain-computer Interface System Applications
Table 28. Global Brain-computer Interface System Sales by Company (K Units) & (2021-2026)
Table 29. Global Brain-computer Interface System Sales Share by Company (2021-2026)
Table 30. Global Brain-computer Interface System Revenue by Company (US$ Million) & (2021-2026)
Table 31. Global Brain-computer Interface System Revenue Share by Company (2021-2026)
Table 32. Global Brain-computer Interface System by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brain-computer Interface System as of 2025)
Table 33. Global Market Brain-computer Interface System Average Price by Company (K US$/Unit) & (2021-2026)
Table 34. Global Key Manufacturers of Brain-computer Interface System, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Brain-computer Interface System, Product Type & Application
Table 36. Global Key Manufacturers of Brain-computer Interface System, Date of Entry into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Brain-computer Interface System Sales by Company (2021-2026) & (K Units)
Table 39. North America Brain-computer Interface System Sales Market Share by Company (2021-2026)
Table 40. North America Brain-computer Interface System Revenue by Company (2021-2026) & (US$ Million)
Table 41. North America Brain-computer Interface System Revenue Market Share by Company (2021-2026)
Table 42. North America Brain-computer Interface System Sales by Type (2021-2026) & (K Units)
Table 43. North America Brain-computer Interface System Sales Market Share by Type (2021-2026)
Table 44. North America Brain-computer Interface System Sales by Application (2021-2026) & (K Units)
Table 45. North America Brain-computer Interface System Sales Market Share by Application (2021-2026)
Table 46. Europe Brain-computer Interface System Sales by Company (2021-2026) & (K Units)
Table 47. Europe Brain-computer Interface System Sales Market Share by Company (2021-2026)
Table 48. Europe Brain-computer Interface System Revenue by Company (2021-2026) & (US$ Million)
Table 49. Europe Brain-computer Interface System Revenue Market Share by Company (2021-2026)
Table 50. Europe Brain-computer Interface System Sales by Type (2021-2026) & (K Units)
Table 51. Europe Brain-computer Interface System Sales Market Share by Type (2021-2026)
Table 52. Europe Brain-computer Interface System Sales by Application (2021-2026) & (K Units)
Table 53. Europe Brain-computer Interface System Sales Market Share by Application (2021-2026)
Table 54. China Brain-computer Interface System Sales by Company (2021-2026) & (K Units)
Table 55. China Brain-computer Interface System Sales Market Share by Company (2021-2026)
Table 56. China Brain-computer Interface System Revenue by Company (2021-2026) & (US$ Million)
Table 57. China Brain-computer Interface System Revenue Market Share by Company (2021-2026)
Table 58. China Brain-computer Interface System Sales by Type (2021-2026) & (K Units)
Table 59. China Brain-computer Interface System Sales Market Share by Type (2021-2026)
Table 60. China Brain-computer Interface System Sales by Application (2021-2026) & (K Units)
Table 61. China Brain-computer Interface System Sales Market Share by Application (2021-2026)
Table 62. Japan Brain-computer Interface System Sales by Company (2021-2026) & (K Units)
Table 63. Japan Brain-computer Interface System Sales Market Share by Company (2021-2026)
Table 64. Japan Brain-computer Interface System Revenue by Company (2021-2026) & (US$ Million)
Table 65. Japan Brain-computer Interface System Revenue Market Share by Company (2021-2026)
Table 66. Japan Brain-computer Interface System Sales by Type (2021-2026) & (K Units)
Table 67. Japan Brain-computer Interface System Sales Market Share by Type (2021-2026)
Table 68. Japan Brain-computer Interface System Sales by Application (2021-2026) & (K Units)
Table 69. Japan Brain-computer Interface System Sales Market Share by Application (2021-2026)
Table 70. Neuralink Company Information
Table 71. Neuralink Description and Business Overview
Table 72. Neuralink Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 73. Neuralink Brain-computer Interface System Product
Table 74. Neuralink Recent Development
Table 75. OpenBCI Company Information
Table 76. OpenBCI Description and Business Overview
Table 77. OpenBCI Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 78. OpenBCI Brain-computer Interface System Product
Table 79. OpenBCI Recent Development
Table 80. NeuroPace Company Information
Table 81. NeuroPace Description and Business Overview
Table 82. NeuroPace Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 83. NeuroPace Brain-computer Interface System Product
Table 84. NeuroPace Recent Development
Table 85. Emotiv Company Information
Table 86. Emotiv Description and Business Overview
Table 87. Emotiv Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 88. Emotiv Brain-computer Interface System Product
Table 89. Emotiv Recent Development
Table 90. NeuroSky Company Information
Table 91. NeuroSky Description and Business Overview
Table 92. NeuroSky Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 93. NeuroSky Brain-computer Interface System Product
Table 94. NeuroSky Recent Development
Table 95. ANT Neuro Company Information
Table 96. ANT Neuro Description and Business Overview
Table 97. ANT Neuro Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 98. ANT Neuro Brain-computer Interface System Product
Table 99. ANT Neuro Recent Development
Table 100. Blackrock Neurotech Company Information
Table 101. Blackrock Neurotech Description and Business Overview
Table 102. Blackrock Neurotech Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 103. Blackrock Neurotech Brain-computer Interface System Product
Table 104. Blackrock Neurotech Recent Development
Table 105. Synchron Company Information
Table 106. Synchron Description and Business Overview
Table 107. Synchron Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 108. Synchron Brain-computer Interface System Product
Table 109. Synchron Recent Development
Table 110. g.tec medical engineering GmbH Company Information
Table 111. g.tec medical engineering GmbH Description and Business Overview
Table 112. g.tec medical engineering GmbH Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 113. g.tec medical engineering GmbH Brain-computer Interface System Product
Table 114. g.tec medical engineering GmbH Recent Development
Table 115. Brain Products Company Information
Table 116. Brain Products Description and Business Overview
Table 117. Brain Products Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 118. Brain Products Brain-computer Interface System Product
Table 119. Brain Products Recent Development
Table 120. Bitbrain Company Information
Table 121. Bitbrain Description and Business Overview
Table 122. Bitbrain Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 123. Bitbrain Brain-computer Interface System Product
Table 124. Bitbrain Recent Development
Table 125. Precision Neuroscience Company Information
Table 126. Precision Neuroscience Description and Business Overview
Table 127. Precision Neuroscience Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 128. Precision Neuroscience Brain-computer Interface System Product
Table 129. Precision Neuroscience Recent Development
Table 130. Paradromics Company Information
Table 131. Paradromics Description and Business Overview
Table 132. Paradromics Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 133. Paradromics Brain-computer Interface System Product
Table 134. Paradromics Recent Development
Table 135. InteraXon Company Information
Table 136. InteraXon Description and Business Overview
Table 137. InteraXon Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 138. InteraXon Brain-computer Interface System Product
Table 139. InteraXon Recent Development
Table 140. Neurable Company Information
Table 141. Neurable Description and Business Overview
Table 142. Neurable Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 143. Neurable Brain-computer Interface System Product
Table 144. Neurable Recent Development
Table 145. Mentalab Company Information
Table 146. Mentalab Description and Business Overview
Table 147. Mentalab Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 148. Mentalab Brain-computer Interface System Product
Table 149. Mentalab Recent Development
Table 150. mBrainTrain Company Information
Table 151. mBrainTrain Description and Business Overview
Table 152. mBrainTrain Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 153. mBrainTrain Brain-computer Interface System Product
Table 154. mBrainTrain Recent Development
Table 155. Neuroelectrics Company Information
Table 156. Neuroelectrics Description and Business Overview
Table 157. Neuroelectrics Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 158. Neuroelectrics Brain-computer Interface System Product
Table 159. Neuroelectrics Recent Development
Table 160. CGX Systems (formerly Cognionics) Company Information
Table 161. CGX Systems (formerly Cognionics) Description and Business Overview
Table 162. CGX Systems (formerly Cognionics) Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 163. CGX Systems (formerly Cognionics) Brain-computer Interface System Product
Table 164. CGX Systems (formerly Cognionics) Recent Development
Table 165. Neurosity Company Information
Table 166. Neurosity Description and Business Overview
Table 167. Neurosity Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 168. Neurosity Brain-computer Interface System Product
Table 169. Neurosity Recent Development
Table 170. Wearable Sensing Company Information
Table 171. Wearable Sensing Description and Business Overview
Table 172. Wearable Sensing Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 173. Wearable Sensing Brain-computer Interface System Product
Table 174. Wearable Sensing Recent Development
Table 175. Compumedics Neuroscan Company Information
Table 176. Compumedics Neuroscan Description and Business Overview
Table 177. Compumedics Neuroscan Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 178. Compumedics Neuroscan Brain-computer Interface System Product
Table 179. Compumedics Neuroscan Recent Development
Table 180. SmartCap(Wenco) Company Information
Table 181. SmartCap(Wenco) Description and Business Overview
Table 182. SmartCap(Wenco) Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 183. SmartCap(Wenco) Brain-computer Interface System Product
Table 184. SmartCap(Wenco) Recent Development
Table 185. Shimadzu Company Information
Table 186. Shimadzu Description and Business Overview
Table 187. Shimadzu Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 188. Shimadzu Brain-computer Interface System Product
Table 189. Shimadzu Recent Development
Table 190. BrainCo Company Information
Table 191. BrainCo Description and Business Overview
Table 192. BrainCo Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 193. BrainCo Brain-computer Interface System Product
Table 194. BrainCo Recent Development
Table 195. Neuracle Technology Company Information
Table 196. Neuracle Technology Description and Business Overview
Table 197. Neuracle Technology Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 198. Neuracle Technology Brain-computer Interface System Product
Table 199. Neuracle Technology Recent Development
Table 200. CUSOFT Company Information
Table 201. CUSOFT Description and Business Overview
Table 202. CUSOFT Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 203. CUSOFT Brain-computer Interface System Product
Table 204. CUSOFT Recent Development
Table 205. Deayea Company Information
Table 206. Deayea Description and Business Overview
Table 207. Deayea Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 208. Deayea Brain-computer Interface System Product
Table 209. Deayea Recent Development
Table 210. Entertech Company Information
Table 211. Entertech Description and Business Overview
Table 212. Entertech Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 213. Entertech Brain-computer Interface System Product
Table 214. Entertech Recent Development
Table 215. HNNK Company Information
Table 216. HNNK Description and Business Overview
Table 217. HNNK Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 218. HNNK Brain-computer Interface System Product
Table 219. HNNK Recent Development
Table 220. StairMed Company Information
Table 221. StairMed Description and Business Overview
Table 222. StairMed Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 223. StairMed Brain-computer Interface System Product
Table 224. StairMed Recent Development
Table 225. NeuroXess Company Information
Table 226. NeuroXess Description and Business Overview
Table 227. NeuroXess Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 228. NeuroXess Brain-computer Interface System Product
Table 229. NeuroXess Recent Development
Table 230. Enlight Medical Company Information
Table 231. Enlight Medical Description and Business Overview
Table 232. Enlight Medical Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 233. Enlight Medical Brain-computer Interface System Product
Table 234. Enlight Medical Recent Development
Table 235. Tiankai Suishi (Tianjin) Intelligent Technology Co., Ltd. Company Information
Table 236. Tiankai Suishi (Tianjin) Intelligent Technology Co., Ltd. Description and Business Overview
Table 237. Tiankai Suishi (Tianjin) Intelligent Technology Co., Ltd. Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 238. Tiankai Suishi (Tianjin) Intelligent Technology Co., Ltd. Brain-computer Interface System Product
Table 239. Tiankai Suishi (Tianjin) Intelligent Technology Co., Ltd. Recent Development
Table 240. Hanix Company Information
Table 241. Hanix Description and Business Overview
Table 242. Hanix Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 243. Hanix Brain-computer Interface System Product
Table 244. Hanix Recent Development
Table 245. Zhongdian Yunnao (Tianjin) Technology Co., Ltd. Company Information
Table 246. Zhongdian Yunnao (Tianjin) Technology Co., Ltd. Description and Business Overview
Table 247. Zhongdian Yunnao (Tianjin) Technology Co., Ltd. Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 248. Zhongdian Yunnao (Tianjin) Technology Co., Ltd. Brain-computer Interface System Product
Table 249. Zhongdian Yunnao (Tianjin) Technology Co., Ltd. Recent Development
Table 250. Beijing Xinzhida Neural Technology Co., Ltd Company Information
Table 251. Beijing Xinzhida Neural Technology Co., Ltd Description and Business Overview
Table 252. Beijing Xinzhida Neural Technology Co., Ltd Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 253. Beijing Xinzhida Neural Technology Co., Ltd Brain-computer Interface System Product
Table 254. Beijing Xinzhida Neural Technology Co., Ltd Recent Development
Table 255. Nanjing Vishee Medical Technology Co., Ltd. Company Information
Table 256. Nanjing Vishee Medical Technology Co., Ltd. Description and Business Overview
Table 257. Nanjing Vishee Medical Technology Co., Ltd. Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 258. Nanjing Vishee Medical Technology Co., Ltd. Brain-computer Interface System Product
Table 259. Nanjing Vishee Medical Technology Co., Ltd. Recent Development
Table 260. Xiangyu Medical Co.,Ltd. Company Information
Table 261. Xiangyu Medical Co.,Ltd. Description and Business Overview
Table 262. Xiangyu Medical Co.,Ltd. Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 263. Xiangyu Medical Co.,Ltd. Brain-computer Interface System Product
Table 264. Xiangyu Medical Co.,Ltd. Recent Development
Table 265. Jiangsu Apon Medical Technology Co.,Ltd. Company Information
Table 266. Jiangsu Apon Medical Technology Co.,Ltd. Description and Business Overview
Table 267. Jiangsu Apon Medical Technology Co.,Ltd. Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 268. Jiangsu Apon Medical Technology Co.,Ltd. Brain-computer Interface System Product
Table 269. Jiangsu Apon Medical Technology Co.,Ltd. Recent Development
Table 270. Production Base and Market Concentration Rate of Raw Material
Table 271. Key Suppliers of Raw Materials
Table 272. Brain-computer Interface System Distributors List
Table 273. Brain-computer Interface System Customers List
Table 274. Brain-computer Interface System Market Trends
Table 275. Brain-computer Interface System Market Drivers
Table 276. Brain-computer Interface System Market Challenges
Table 277. Brain-computer Interface System Market Restraints
Table 278. Research Programs/Design for This Report
Table 279. Key Data Information from Secondary Sources
Table 280. Key Data Information from Primary Sources
List of Figures
Figure 1. Brain-computer Interface System Product Picture
Figure 2. Global Brain-computer Interface System Sales (US$ Million) by Type (2021, 2025 & 2032)
Figure 3. Global Brain-computer Interface System Sales Market Share by Type in 2025 & 2032
Figure 4. Non-Invasive Product Picture
Figure 5. Partially Invasive Product Picture
Figure 6. Invasive Product Picture
Figure 7. Global Brain-computer Interface System Sales (US$ Million) by Application (2021, 2025 & 2032)
Figure 8. Global Brain-computer Interface System Sales Market Share by Application in 2025 & 2032
Figure 9. Medical Rehabilitation Examples
Figure 10. Daily Life and Entertainment Consumption Examples
Figure 11. Industrial Control Examples
Figure 12. Traffic Driving Examples
Figure 13. Research & Education Examples
Figure 14. Military and Others Examples
Figure 15. Global Brain-computer Interface System Sales, (US$ Million), 2021 VS 2025 VS 2032
Figure 16. Global Brain-computer Interface System Sales Growth Rate (2021-2032) & (US$ Million)
Figure 17. Global Brain-computer Interface System Sales (K Units) Growth Rate (2021-2032)
Figure 18. Global Brain-computer Interface System Price Trends Growth Rate (2021-2032) & (K US$/Unit)
Figure 19. Brain-computer Interface System Report Years Considered
Figure 20. Global Market Brain-computer Interface System Market Size (US$ Million) by Region:2021 VS 2025 VS 2032
Figure 21. Global Brain-computer Interface System Revenue Market Share by Region: 2021 VS 2025
Figure 22. North America Brain-computer Interface System Revenue (US$ Million) Growth Rate (2021-2032)
Figure 23. North America Brain-computer Interface System Sales (K Units) Growth Rate (2021-2032)
Figure 24. Europe Brain-computer Interface System Revenue (US$ Million) Growth Rate (2021-2032)
Figure 25. Europe Brain-computer Interface System Sales (K Units) Growth Rate (2021-2032)
Figure 26. China Brain-computer Interface System Revenue (US$ Million) Growth Rate (2021-2032)
Figure 27. China Brain-computer Interface System Sales (K Units) Growth Rate (2021-2032)
Figure 28. Japan Brain-computer Interface System Revenue (US$ Million) Growth Rate (2021-2032)
Figure 29. Japan Brain-computer Interface System Sales (K Units) Growth Rate (2021-2032)
Figure 30. Global Brain-computer Interface System Revenue Share by Type (2021-2026)
Figure 31. Global Brain-computer Interface System Sales Share by Type (2027-2032)
Figure 32. Global Brain-computer Interface System Revenue Share by Type (2027-2032)
Figure 33. Global Brain-computer Interface System Revenue Share by Application (2021-2026)
Figure 34. Global Brain-computer Interface System Revenue Market Share by Application in 2021 & 2025
Figure 35. Global Brain-computer Interface System Sales Share by Application (2027-2032)
Figure 36. Global Brain-computer Interface System Revenue Share by Application (2027-2032)
Figure 37. Global Brain-computer Interface System Sales Share by Company (2025)
Figure 38. Global Brain-computer Interface System Revenue Share by Company (2025)
Figure 39. Global 5 Largest Brain-computer Interface System Players Market Share by Revenue in Brain-computer Interface System: 2021 & 2025
Figure 40. Brain-computer Interface System Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 41. Manufacturing Cost Structure of Brain-computer Interface System
Figure 42. Manufacturing Process Analysis of Brain-computer Interface System
Figure 43. Brain-computer Interface System Industrial Chain
Figure 44. Channels of Distribution (Direct Vs Distribution)
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which region is expected to have the highest market share?
For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 20.4% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.
Which companies rank high in the global Brain-computer Interface System market?
What was the global market size of Brain-computer Interface System in 2032?
What is the annual compound growth rate of the global Brain-computer Interface System market size from 2026 to 2032?
What was the global market size of Brain-computer Interface System in 2026?
Related Reports
Brain-computer Interface System- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Brain-computer Interface System was estimated to be worth US$ 836 million in 2025 and is projected to reach US$ 2962 million, growing at a CAGR of 20.4% from 2026 to 2032.
Published Date: 2026-07-26
Pages: 195
USD 3950.00
(Single User License)
Global Brain-computer Interface System Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Brain-computer Interface System market is projected to grow from US$ 836 million in 2025 to US$ 2962 million by 2032, at a CAGR of 20.4% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-07-26
Pages: 228
USD 4900.00
(Single User License)
Global Brain-computer Interface System Market Research Report 2026
The global Brain-computer Interface System market was valued at US$ 836 million in 2025 and is anticipated to reach US$ 2962 million by 2032, at a CAGR of 20.4% from 2026 to 2032.
Published Date: 2026-07-26
Pages: 161
USD 2900.00
(Single User License)
Global Brain-computer Interface System Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Brain-computer Interface System market is projected to grow from US$ 186 million in 2024 to US$ 223 million by 2031, at a CAGR of 2.7% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-23
Pages: 134
USD 4900.00
(Single User License)
Global Brain-computer Interface System Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Brain-computer Interface System market size was US$ 186 million in 2024 and is forecast to a readjusted size of US$ 223 million by 2031 with a CAGR of 2.7% during the forecast period 2025-2031.
Published Date: 2025-02-20
Pages: 96
USD 4250.00
(Single User License)
Brain-computer Interface System- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Brain-computer Interface System was estimated to be worth US$ 186 million in 2024 and is forecast to a readjusted size of US$ 223 million by 2031 with a CAGR of 2.7% during the forecast period 2025-2031.
Published Date: 2025-02-20
Pages: 113
USD 3950.00
(Single User License)
Global Brain-computer Interface System Market Research Report 2025
The global market for Brain-computer Interface System was valued at US$ 186 million in the year 2024 and is projected to reach a revised size of US$ 223 million by 2031, growing at a CAGR of 2.7% during the forecast period.
Published Date: 2025-02-20
Pages: 88
USD 2900.00
(Single User License)
Global Brain-computer Interface System Market Insights, Forecast to 2030
Market Analysis and Insights: Global Brain-computer Interface System Market
Published Date: 2024-04-08
Pages: 114
USD 4900.00
(Single User License)
Brain-computer Interface System - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Brain-computer Interface System was estimated to be worth US$ 177 million in 2023 and is forecast to a readjusted size of US$ 212.7 million by 2030 with a CAGR of 2.7% during the forecast period 2024-2030
Published Date: 2024-02-22
Pages: 106
USD 3950.00
(Single User License)
Global Brain-computer Interface System Market Research Report 2024
The global Brain-computer Interface System market was valued at US$ 177 million in 2023 and is anticipated to reach US$ 212.7 million by 2030, witnessing a CAGR of 2.7% during the forecast period 2024-2030.
Published Date: 2024-01-17
Pages: 83
USD 2900.00
(Single User License)
Brain-computer Interface System- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Brain-computer Interface System was estimated to be worth US$ 836 million in 2025 and is projected to reach US$ 2962 million, growing at a CAGR of 20.4% from 2026 to 2032.
Published: 2026-07-26
Pages: 195
USD 3950.00 (Single User License)Global Brain-computer Interface System Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Brain-computer Interface System market is projected to grow from US$ 836 million in 2025 to US$ 2962 million by 2032, at a CAGR of 20.4% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-07-26
Pages: 228
USD 4900.00 (Single User License)Global Brain-computer Interface System Market Research Report 2026
The global Brain-computer Interface System market was valued at US$ 836 million in 2025 and is anticipated to reach US$ 2962 million by 2032, at a CAGR of 20.4% from 2026 to 2032.
Published: 2026-07-26
Pages: 161
USD 2900.00 (Single User License)Global Brain-computer Interface System Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Brain-computer Interface System market is projected to grow from US$ 186 million in 2024 to US$ 223 million by 2031, at a CAGR of 2.7% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-23
Pages: 134
USD 4900.00 (Single User License)Global Brain-computer Interface System Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Brain-computer Interface System market size was US$ 186 million in 2024 and is forecast to a readjusted size of US$ 223 million by 2031 with a CAGR of 2.7% during the forecast period 2025-2031.
Published: 2025-02-20
Pages: 96
USD 4250.00 (Single User License)Brain-computer Interface System- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Brain-computer Interface System was estimated to be worth US$ 186 million in 2024 and is forecast to a readjusted size of US$ 223 million by 2031 with a CAGR of 2.7% during the forecast period 2025-2031.
Published: 2025-02-20
Pages: 113
USD 3950.00 (Single User License)Global Brain-computer Interface System Market Research Report 2025
The global market for Brain-computer Interface System was valued at US$ 186 million in the year 2024 and is projected to reach a revised size of US$ 223 million by 2031, growing at a CAGR of 2.7% during the forecast period.
Published: 2025-02-20
Pages: 88
USD 2900.00 (Single User License)Global Brain-computer Interface System Market Insights, Forecast to 2030
Market Analysis and Insights: Global Brain-computer Interface System Market
Published: 2024-04-08
Pages: 114
USD 4900.00 (Single User License)Brain-computer Interface System - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Brain-computer Interface System was estimated to be worth US$ 177 million in 2023 and is forecast to a readjusted size of US$ 212.7 million by 2030 with a CAGR of 2.7% during the forecast period 2024-2030
Published: 2024-02-22
Pages: 106
USD 3950.00 (Single User License)Global Brain-computer Interface System Market Research Report 2024
The global Brain-computer Interface System market was valued at US$ 177 million in 2023 and is anticipated to reach US$ 212.7 million by 2030, witnessing a CAGR of 2.7% during the forecast period 2024-2030.
Published: 2024-01-17
Pages: 83
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4250.00
USD 6375.00
USD 8500.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
KEY FINDINGS
OVERVIEW
MARKET TRENDS
MARKET SEGMENTATION
MARKET DYNAMICS
INDUSTRY CHAIN ANALYSIS
SEGMENT INSIGHTS
DOWNSTREAM MARKET OPPORTUNITIES
REGIONAL INSIGHTS
COMPETITIVE LANDSCAPE ANALYSIS
REPORT SCOPE
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now